
National Health Investors
(NYSE) NHI
| Metric | Price | Date |
|---|---|---|
| Last close | USD 79.14 | 2026-07-16 |
| Period | Price return | Price at period start | Period start date |
|---|---|---|---|
| 1 week | +3.94% | USD 76.14 | 2026-07-09 |
| 1 month | +11.83% | USD 70.77 | 2026-06-16 |
| 3 month | -6.49% | USD 84.63 | 2026-04-17 |
| Year to date | +6.05% | USD 74.62 | 2025-12-31 |
| 1 year | +17.37% | USD 67.43 | 2025-07-16 |
| 3 year | +72.18% | USD 45.96 | 2023-07-17 |
| 5 year | +55.56% | USD 50.87 | 2021-07-16 |
| Since inception | +4,426.42% | USD 1.75 | 1991-10-09 |
National Health Investors Financials at a Glance
Market Cap
Revenue (TTM)
Net Income (TTM)
EPS (TTM)
P/E Ratio
Dividend
Beta (Volatility)
Dividend
Beta (Volatility)
Price
Volume
Open
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
Dividend
Beta (Volatility)
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
NHI News
National Health Keeps Dividend Steady
NHI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout National Health Investors
Industry
Health Care REITs
Sector
Real EstateEmployees
32
CEO
D. Eric Mendelsohn
Website
www.nhireit.comHeadquarters
Murfreesboro, TN 37129, US
NHI Financials
Key Financial Metrics (TTM)
Gross Margin
Operating Margin
Net Income Margin
Return on Equity
Return on Capital
Return on Assets
Earnings Yield
Dividend Yield
Payout Ratio
Stock Overview
Market Cap
Shares Outstanding
Volume
Avg. Volume
Financials (TTM)
Gross Profit
Operating Income
EBITDA
Operating Cash Flow
Capital Expenditure
Free Cash Flow
Cash & ST Invst.
Total Debt
National Health Investors Performance Analysis
| Fiscal year | Period end | Revenue | YoY growth |
|---|---|---|---|
| 2022 | 2022-12-31 | USD 285,749,000 | -2.3% |
| 2023 | 2023-12-31 | USD 322,356,000 | 12.8% |
| 2024 | 2024-12-31 | USD 338,074,000 | 4.9% |
| 2025 | 2025-12-31 | USD 378,529,000 | 12.0% |
| Fiscal quarter | Period end | QoQ growth |
|---|---|---|
| Q2 | 2025-06-30 | 1.5% |
| Q3 | 2025-09-30 | -0.9% |
| Q4 | 2025-12-31 | 18.6% |
| Q1 | 2026-03-31 | 8.7% |
| Fiscal year | Period end | Diluted EPS | YoY growth |
|---|---|---|---|
| 2022 | 2022-12-31 | USD 1.48 | -39.4% |
| 2023 | 2023-12-31 | USD 3.13 | 110.8% |
| 2024 | 2024-12-31 | USD 3.13 | 0.0% |
| 2025 | 2025-12-31 | USD 3.02 | -3.5% |
| Fiscal quarter | Period end | QoQ growth |
|---|---|---|
| Q2 | 2025-06-30 | 6.8% |
| Q3 | 2025-09-30 | -12.7% |
| Q4 | 2025-12-31 | 15.9% |
| Q1 | 2026-03-31 | 2.5% |
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
+29.7%
Gross Profit
-58.3%
Gross Margin
N/A
Market Cap
N/A
Market Cap/Employee
N/A
Employees
N/A
Net Income
+17.4%
EBITDA
+19.4%
Quarterly Fundamentals
Total Cash
-81.5%
Total Debt
+0.5%
Accounts Receivable
-17.2%
Inventory
N/A
Long Term Debt
+17.8%
Short Term Debt
-30.9%
Return on Assets
N/A
Return on Invested Capital
N/A
Free Cash Flow
+13.1%
Operating Cash Flow
+14.0%




